Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
出版年份 2015 全文链接
标题
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
作者
关键词
-
出版物
LEUKEMIA
Volume 30, Issue 5, Pages 1126-1132
出版商
Springer Nature
发表日期
2015-12-29
DOI
10.1038/leu.2015.360
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
- (2015) F Palandri et al. LEUKEMIA
- Discriminating between essential thrombocythemia and masked polycythemia vera inJAK2mutated patients
- (2014) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Essential thrombocythemia vs. early/prefibrotic myelofibrosis: Why does it matter
- (2014) Giovanni Barosi BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia
- (2014) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes
- (2014) Alberto Alvarez-Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
- (2014) A Tefferi et al. LEUKEMIA
- World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-The Danish experience
- (2013) Ann Brinch Madelung et al. AMERICAN JOURNAL OF HEMATOLOGY
- Masked polycythemia Vera (mPV): Results of an international study
- (2013) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Masked polycythemia vera diagnosed according to WHO and BCSH classification
- (2013) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
- (2013) R. T. Silver et al. BLOOD
- Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
- (2013) H. Gisslinger et al. BLOOD
- Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia
- (2013) T Barbui et al. LEUKEMIA
- Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2013) Umberto Gianelli et al. MODERN PATHOLOGY
- Guideline for the diagnosis and management of myelofibrosis
- (2012) John T. Reilly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
- (2012) Elisabeth Ejerblad et al. Hematology
- Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
- (2012) Giovanni Barosi et al. PLoS One
- Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
- (2011) J. Thiele et al. BLOOD
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
- (2011) T. Buhr et al. HAEMATOLOGICA
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
- (2011) G Finazzi et al. LEUKEMIA
- Guideline for investigation and management of adults and children presenting with a thrombocytosis
- (2010) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera
- (2010) Khadija Abdulkarim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis
- (2010) Maud Brousseau et al. HISTOPATHOLOGY
- Thrombosis in primary myelofibrosis: incidence and risk factors
- (2009) T. Barbui et al. BLOOD
- The Significance of Bone Marrow Biopsy andJAK2V617FMutation in the Differential Diagnosis Between the “Early” Prepolycythemic Phase of Polycythemia Vera and Essential Thrombocythemia
- (2008) Umberto Gianelli et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis
- (2008) Juergen Thiele et al. Current Hematologic Malignancy Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search